22 §8732. Drug price notifications and disclosures

22 ME Rev Stat § 8732 (2019) (N/A)
Copy with citation
Copy as parenthetical citation

§8732. Drug price notifications and disclosures

1.  Notifications by manufacturers.  No later than January 30, 2020 and annually thereafter, a manufacturer shall notify the organization when the manufacturer has during the prior calendar year:

A. Increased the wholesale acquisition cost of a brand-name drug by more than 20% per pricing unit;   [PL 2019, c. 470, §8 (NEW).]

B. Increased the wholesale acquisition cost of a generic drug that costs at least $10 per pricing unit by more than 20% per pricing unit; or   [PL 2019, c. 470, §8 (NEW).]

C. Introduced a new drug for distribution in this State when the wholesale acquisition cost is greater than the amount that would cause the drug to be considered a specialty drug under the Medicare Part D program. For the purposes of this subsection, "Medicare Part D" has the same meaning as in section 254‑D, subsection 1, paragraph F.   [PL 2019, c. 470, §8 (NEW).]

[PL 2019, c. 470, §8 (NEW).]

2.  Disclosures by manufacturers, wholesale drug distributors and pharmacy benefits managers.  Within 60 days of a request from the organization relating to a specific prescription drug, a manufacturer, wholesale drug distributor or pharmacy benefits manager shall notify the organization of pricing component data per pricing unit of a drug.

[PL 2019, c. 470, §8 (NEW).]

SECTION HISTORY

PL 2019, c. 470, §8 (NEW).